Sun Pharma launches multifaceted initiatives under Sunkalp for welfare of doctors

Published On 2021-07-02 04:30 GMT | Update On 2021-07-05 08:22 GMT

Mumbai: Sun Pharmaceutical Industries Ltd. has announced the launch of a special initiative 'Sunkalp' for the welfare of doctors, their families and the community.

Doctors have been working relentlessly through the pandemic putting their lives at risk to safeguard society.

To recognise and care for their health & well-being, on the occasion of National Doctors' Day, Sun Pharma has announced the launch of multifaceted initiatives under Sunkalp.

These initiatives will be rolled out in a phased manner:

. Mental health support for doctors & their families

. Webinars for doctors on mental health by experts

. Donation of Covid-19 medicines (phase 2)

. Post Doctorate educational sponsorship (phase 2)

. Educational aid for children of doctors who lost their lives to Covid-19 (phase 2)

Sun Pharma has committed Rs. 100 crores towards these initiatives, which includes donation of Covid19 medicines to communities at large through local & state government institutions.

"For more than a year, doctors have been fighting the pandemic to save lives. Long stressful working hours, witnessing casualties and maintaining distance from loved ones have become normal for them. These factors can result in stress & exhaustion not only for them but also for their families. To help them cope with the same, Sun Pharma has partnered with Mann Talks to provide doctors and their families with confidential emotional and psychological care by trained mental health professionals." the company said.

Further, to educate doctors on mental health issues & enable them to take better selfcare, multiple webinars will be held by experts.

Kirti Ganorkar, CEO – India Business, Sun Pharma, said, "Indian healthcare professionals have faced unprecedented challenges during the pandemic, and their determination to fight against all odds inspires us every day. Sunkalp is a tribute to these heroes for their selfless acts of sacrifice and kindness. Through this initiative, we want to extend our gratitude to them and contribute to strengthening the healthcare ecosystem."

The pandemic outbreak has affirmed the need for more medical research to meet unforeseen situations. To encourage research, Sun Pharma will sponsor postgraduate medical students for medical & clinical research in various fields. More than 1000 young scholars will receive grants for their research projects.

To pay homage to doctors who have lost their lives to Covid-19, Sun Pharma is setting up an Education Fund for their children. The company will provide educational grants to the affected families through this fund.

The Sunkalp initiative is restricted to India.

Read also: Sun Pharma gets CDSCO panel ok for BE study of Sitagliptin, Metformin, Glimepiride FDC

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Comments Policy

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Sun Pharma launches multifaceted initiatives under Sunkalp for welfare of doctors

Similar News

Lupin partners with Sandoz to market, commercialize Ranibizumab biosimilar across multiple regions

Intas Pharma, Accord signs agreement to buy Prothya Biosolutions

Gland Pharma secures USFDA okay for Norepinephrine Bitartrate in 5% Dextrose Injection Bags

UCPMP 2024: Govt Details Stricter Rules to Curb Gifts, Incentives from Pharma to Doctors

AIOCD Opposes Karnataka's Third-Party Pharmacy Inspection Plan, Warns of Legal, Data Risks

Sun Pharma's Phase IV Study on Dual Release Pantoprazole for GERD Gets CDSCO Panel Acceptance

Draft Rules Set to Regulate Online Sale of Addictive Painkillers, Psychotropic Drugs: Govt

GSK Gepotidacin accepted for priority review by USFDA for oral treatment of uncomplicated urogenital gonorrhoea